Literature DB >> 20005398

Multipotent progenitor cells derived from human umbilical cord blood can differentiate into hepatocyte-like cells in a liver injury rat model.

Y J Moon1, H H Yoon, M W Lee, I K Jang, D-H Lee, J-H Lee, S-K Lee, K-H Lee, Y J Kim, Y-W Eom.   

Abstract

Umbilical cord blood (UCB), a rich source of hematopoietic stem cells, offers practical and ethical advantages. It has been reported that various adult stem cells transplanted into a damaged liver show characteristics of a hepatic lineage. In a previous study, we reported on novel UCB-derived adult stem cells, termed umbilical cord blood-derived multipotent progenitor cells (UCB-MPCs). We demonstrated that these cells were capable of differentiating into hepatocyte- like cells in vitro. To assess the hepatic differentiation capacity of UCB-MPCs, rat models of hepatic injury were generated using carbon tetra-chloride (CCl(4)) with transplantation of cells into the liver. The transplanted cells successfully incorporated into the liver of the recipient animal differentiated into functional hepatocyte-like cells that expressed hepatocyte-specific markers, such as CK-18 and albumin. Moreover, human albumin was detected in the serum of the recipient rat model. These data indicated that UCB-MPCs were capable of displaying similar characteristics to those of functional hepatocytes in a recipient liver. UCB-MPCs may prove to be a useful, transplantable alternative for hepatic progenitor cells in both experimental and therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005398     DOI: 10.1016/j.transproceed.2009.08.053

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

1.  A comparison of the chemical and liver extract-induced hepatic differentiation of adipose derived stem cells.

Authors:  Truong Hai Nhung; Nguyen Hai Nam; Nguyen Thi Kim Nguyen; Huynh Nghia; Nguyen Van Thanh; Phan Kim Ngoc; Phuc Van Pham
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-08-15       Impact factor: 2.416

2.  Reversal of Hepatic Fibrosis by Human CD34(+) Stem/Progenitor Cell Transplantation in Rats.

Authors:  M T Abdel Aziz; Mf El Asmar; S Mostafa; H Salama; H M Atta; S Mahfouz; N K Roshdy; L A Rashed; D Sabry; N Hasan; M Mahmoud; D Elderwy
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

Review 3.  Stem and progenitor cells in human umbilical cord blood.

Authors:  Myoung Woo Lee; In Keun Jang; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

Review 4.  Plasticity of human menstrual blood stem cells derived from the endometrium.

Authors:  Jian Lin; Dennis Xiang; Jin-long Zhang; Julie Allickson; Charlie Xiang
Journal:  J Zhejiang Univ Sci B       Date:  2011-05       Impact factor: 3.066

5.  Beneficial effects of non-matched allogeneic cord blood mononuclear cells upon patients with idiopathic osteoporosis.

Authors:  Jun Li; Li Zhang; Liang Zhou; Zheng-Ping Yu; Feng Qi; Bei Liu; Su-Xia Zi; Li Li; Yi Li; San-Bin Wang; Zheng-Jiang Cui; Xing-Hua Pan
Journal:  J Transl Med       Date:  2012-05-21       Impact factor: 5.531

6.  Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions.

Authors:  Wan-Zhang Yang; Yun Zhang; Fang Wu; Wei-Ping Min; Boris Minev; Min Zhang; Xiao-Ling Luo; Famela Ramos; Thomas E Ichim; Neil H Riordan; Xiang Hu
Journal:  J Transl Med       Date:  2010-08-03       Impact factor: 5.531

7.  Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload.

Authors:  Saji Oommen; Satsuki Yamada; Susana Cantero Peral; Katherine A Campbell; Elizabeth S Bruinsma; Andre Terzic; Timothy J Nelson
Journal:  Stem Cell Res Ther       Date:  2015-03-26       Impact factor: 6.832

8.  Umbilical cord blood stem cells transplantation as an adjunctive treatment strategy for liver cirrhosis in Chinese population: a meta-analysis of effectiveness and safety.

Authors:  Huimin Tao; Yafeng Li; Tingting Wang; Changhui Zhou
Journal:  Ther Clin Risk Manag       Date:  2018-02-26       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.